Shamik J. Parikh's most recent trade in Humacyte Inc was a trade of 7,500 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on April 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | Shamik J. Parikh | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 10 Apr 2025 | 7,500 | 7,500 | - | 1.6 | 11,625 | Common Stock |
| Humacyte Inc | Shamik J. Parikh | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 283,101 | 283,101 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | J. Parikh Shamik | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 283,000 | 283,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Shamik J. Parikh | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 91,120 | 91,120 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Shamik J. Parikh | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 144,927 | 144,927 | - | - | Stock Options (right to buy) |